Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitating the Impact of Plerixafor Alone or in Combination With Bortezomib on Plasma Cell Mobilization and the Subsequent Impact on HLA Antibody Levels

NCT02522572 is registered in ClinicalTrials.gov with E. Steve Woodle as lead sponsor.

NCT NCT02522572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02522572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitating the Impact of Plerixafor Alone or in Combination With Bortezomib on Plasma Cell Mobilization and the Subsequent Impact on HLA Antibody Levels
Lead sponsor
E. Steve Woodle
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 31, 2015
Completion date
October 31, 2020
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

transplants and implants